The efferent vessel of hepatocellular carcinoma (HCC) and the mechanism and pathogenesis of the high frequency of intrahepatic metastasis in HCC has not yet been clarified. Three hundred ninety-three resected specimens of HCC were examined for tumor thrombosis in the portal vein and the hepatic vein: 231 tumors <-5 cm in diameter were examined for the relationship between mode of tumor spread and tumor size. Efferent vessels in HCC were identified by direct injection of radiopaque material into the tumor in 23 resected liver specimens and by percutaneous infusion of radiopaque media into tumor nodules in 8 patients. The mode of tumor spread in HCC progressed from capsular invasion to extracapsular invasion, then to vascular invasion, and finally to intrahepatic metastasis. There was a strong statistical correlation between the presence of intrahepatic metastasis and portal vein thrombosis (p<0.05, R=0.998). Radiopaque material injected directly into 23 resected tumors entered only the portal vein in 17 tumors and into both the portal and hepatic veins in 6 tumors. In all 8 patients with unresectable lesions, radiopaque media injected percutaneously into tumor nodules flowed only into the portal vein. These findings suggest that intrahepatic invasion by HCC may occur through the portal vein as an efferent tumor vessel.
INTRODUCTION
The prognosis ofhepatocellular carcinoma (HCC) has improved in recent years. This is the result of refined surgical techniques, early detection of small tumors by advances in imaging techniques and biochemical diagnosis, and the introduction of percutaneous arterial embolization and ethanol infusion therapy. [1] [2] [3] [4] [5] However, the prognosis of HCC remains relatively poor because of the high frequency of multiple hepatic tumors, although patients rarely have distant metastases at the time of surgery 1' 6, 7. There are some cases of multicentric origin 7 1'5'9-12 because HCC has a high frequency of tumor invasion into the portal vein system. The mechanism and pathogenesis of the high frequency of intrahepatic metastasis and portal invasion in HCC has not yet been clarified. To investigate the mechanism of intrahepatic metastasis and portal invasion, the pathological, radiological, and morphological studies were undergone to evaluate the efferent tumor vessels in HCC.
MATERIALS AND METHODS
Four hundred and seventy-two patients with HCC underwent resection between April 1980 and December 1993 in our department; of those patients, 393 who underwent subsegmentectomy or larger resection were selected for entry into the study. The other patients who had smaller resection than subseg-mentectomy, such as enucleation of the tumor or wedge resection of the tumor due to liver dysfunction were excluded from the study, because intrahepatic metastatic lesions could not be examined adequately.
The resected specimens were sliced at a thickness of about cm, and all of the slices were macroscopically examined for tumor thrombosis in the portal and hepatic veins. Two to three slices including the maximum cut-surface of the tumor were histologically examined over the total cut-surface. The frequency of capsular invasion, extracapsular invasion, vascular invasion, and intrahepatic metastasis were noted. Tissues were fixed in 10% buffered formalin and embedded in paraffin, processed routinely, and stained with hematoxylin and eosin. Selected sections were stained with periodic acid-Schiff (PAS), Masson trichrome, elastica-van Gieson, and silver impregnation.
Of the 393 total specimens, 231 showed tumors -<5 cm in diameter. Of these, 23 (10%) were selected at random for radiographic evaluation. Radiopaque media was manually infused directly into the tumor immediately after hepatectomy using a 27 gauge needle with a low injection pressure and specimen radiographs were obtained. Specimens were then fixed and serially sectioned, and efferent tumor vessels were histopathologically evaluated. In 7 specimens, radiopaque media was infused into the portal vein, and the vasculature of the portal system around the tumor was evaluated in a similar fashion. In 3 specimens, molds of efferent tumor vessels were produced by infusing silicon rubber directly into the resected tumor.
In 8 An abundant vascular network was noted in tumor capsules, and communicating branches between blood spaces in the tumor and this vascular network were observed in all cases. Serial sections showed that tumor cells were disseminated through these communicating branches and were also present within the vascular network of the capsule in most of the resected specimens. Tumor cells also were often noted within extracapsular blood vessels. Tumor cell infiltration to the intra-and extracapsular blood vessels was seen at many sites of all circumference ( Figure 1 ). (Figure 3 ).
Siliconized rubber was infused into the tumor in three cases, and the interior of the tumor and the portal system around the tumor were visualized.
Many portal branches around the tumor capsule penetrated directly into the interior of the tumor via fine communicating vessels (Figure 4 ).
The portal system around the primary tumor was examined radiographically in 8 patients with unresectable HCC by infusing radiopaque media directly into One possible objection may be that this study only proves that there were communications between the portal branches and the tumor, but cannot show that the portal vein serves as an efferent vessel. However, when contrast medium was injected into the tumor using a low injection pressure, contrast media entered the tumor with little resistance and flowed immediately out into the portal branches, suggesting that the contrast media was injected into vessels. Arteriography of HCCs generally shows hypervascularity. Abundant flow from the hepatic artery feeds the tumor, and arterial blood flows through the blood space into the tumor. Therefore, the pressure of blood flow into the tumor is much higher than that of the portal vein. Moreover, direct portal infusion of contrast media did not enter the tumor, although the portal area surrounding the tumor was fully opacified. Therefore we propose that the portal venous flow cannot enter the tumor, but serves only as an efferent vessel, and that the arterial vessels ordinarily serve as afferent vessels. The current study is the first in which efferent vessels in HCC were identified by direct infusion of radiopaque material into the tumor.
Our data suggests that efferent vessels penetrating the tumor capsule are the path of least resistance for tumor escape. We showed that tumor cells can invade efferent vessels, were engorged in the vascular cavity, and extend beyond the capsule to branches of the portal vein. This may be the major mechanism for the formation of tumor thrombi within the portal vein. It is also hypothesized that tumor fragments may disseminate via portal vein branches to form peripheral intrahepatic metastatic lesions. Tumor thr0mbi generally are fed by an artery of the primary tumor15 '18. However, when thrombi of tumor fragments detach from the tumor and flow into the portal blood stream, they can survive in the portal blood. Then, they adhear to the portal vein wall and obtain their blood supply from the surrounding arterioles. Thus, the portal vein acts as a viable conduit for drainage of the blood feeding the tumor and even for tumor infiltration and spread. (Figure 6 ). 
